Ignite Creation Date:
2024-05-05 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00132015
Status:
COMPLETED
Last Update Posted:
2012-03-15
First Post:
2005-08-16
Brief Title:
17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Systemic Mastocytosis
Sponsor:
National Institutes of Health Clinical Center CC
Organization:
National Institutes of Health Clinical Center CC
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Precancerous Condition |
| Chronic Myeloproliferative Disorders |
| Leukemia |
| Lymphoma |
| Nonneoplastic Condition |
Keywords:
| Name | View |
|---|---|
| Waldenström macroglobulinemia | View |
| multicentric Castleman disease | View |
| unicentric Castleman disease | View |
| adult grade III lymphomatoid granulomatosis | View |
| polycythemia vera | View |
| essential thrombocythemia | View |
| hairy cell leukemia | View |
| monoclonal gammopathy of undetermined significance | View |
| adult Burkitt lymphoma | View |
| adult diffuse large cell lymphoma | View |
| adult diffuse mixed cell lymphoma | View |
| adult diffuse small cleaved cell lymphoma | View |
| adult immunoblastic large cell lymphoma | View |
| adult lymphoblastic lymphoma | View |
| grade 1 follicular lymphoma | View |
| grade 2 follicular lymphoma | View |
| grade 3 follicular lymphoma | View |
| mantle cell lymphoma | View |
| marginal zone lymphoma | View |
| small lymphocytic lymphoma | View |
| precancerous condition | View |